REFERENCES
- Ellinwood E H, Jr, Kilbey M M. Fundamental mechanisms underlying altered behavior following chronic administration of psychomotor stimulants. Biol Psychiatry 1980; 15: 749–757
- Satel S L, Southwick S M, Gawin F H. Clinical features of cocaine-induced paranoia. Am J Psychiatry 1991; 148: 495–498
- McKetin R, McLaren J, Lubman D I, Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2006; 101: 1473–1478
- Brady K T, Lydiard R B, Malcolm R, Ballenger J C. Cocaine-induced psychosis. J Clin Psychiatry 1991; 52: 509–512
- Iwanami A, Sugiyama A, Kuroki N, et al. Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. A preliminary report. Acta Psychiatr Scand 1994; 89: 428–432
- Cook C E. Pyrolytic characteristics, pharmacokinetics, and bioavailability of smoked heroin, cocaine, phencyclidine, and methamphetamine. NIDA Res Monogr 1991; 115: 6–23
- Newton T F, Roache J D, De La Garza R, II, et al. Safety of intravenous methamphetamine administration during treatment with bupropion. Psychopharmacology (Berl) 2005; 182: 426–435
- Javaid J I, Musa M N, Fischman M, Schuster C R, Davis J M. Kinetics of cocaine in humans after intravenous and intranasal administration. Biopharm Drug Dispos 1983; 4: 9–18
- Spitzer R L, Williams J B, Gibbon M, First M B. The Structured Clinical Interview for DSM-III-R (SCID), I: history, rationale, and description. Arch Gen Psychiatry 1992; 49: 624–629
- Sheehan D V, Lecrubier Y, Sheehan K H, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 22–33, (SuPeople. 20);quiz 34–57
- McLellan A T, Kushner H, Metzger D, et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9: 199–213
- Beck A T, Steer R A, Ball R, Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess 1996; 67: 588–597
- Kalayasiri R, Sughondhabirom A, Gueorguieva R, et al. Self-reported paranoia during laboratory “binge” cocaine self-administration in humans. Pharmacol Biochem Behav 2006; 83: 249–256
- Blazer D G, Hays J C, Salive M E. Factors associated with paranoid symptoms in a community sample of older adults. Gerontologist 1996; 36: 70–75
- Kalayasiri R, Kranzler H R, Weiss R, et al. Risk factors for cocaine-induced paranoia in cocaine-dependent sibling pairs. Drug Alcohol Depend 2006; 84: 77–84
- Bartlett E, Hallin A, Chapman B, Angrist B. Selective sensitization to the psychosis-inducing effects of cocaine: a possible marker for addiction relapse vulnerability?. Neuropsychopharmacology 1997; 16: 77–82
- Cantor-Graae E, Zolkowska K, McNeil T F. Increased risk of psychotic disorder among immigrants in Malmo: a three-year first-contact study. Psychol Med 2005; 35: 1155–1163
- Curran C, Byrappa N, McBride A. Stimulant psychosis: systematic review. Br J Psychiatry 2004; 185: 196–204
- Angrist B, Sathananthan G, Wilk S, Gershon S. Amphetamine psychosis: behavioral and biochemical aspects. J Psychiatr Res 1974; 11: 13–23